Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 251961 - 251980 out of 498644 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
Greece | (L04AE01) fingolimod (adm: O) | LOGNIF® CAPS 0.5MG/CAP BT X 28 (ΣΕ BLISTER OPA/AL/PVC/AL) | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | TEVAGMBH,GERMANY |
Greece | (L04AE02) ozanimod (adm: O) | ZEPOSIA CAPS 0.46MG/CAP Συσκευασία έναρξης θεραπείας BTx7 καψάκια (4x0.23mg + 3x0.46mg) σε Βlisters PVC/PCTFE/alu | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting;Colitis, Ulcerative | BRISTOL-MYERSSQUIBBPHARMAEEIG,IRELAND |
Greece | (L04AE02) ozanimod (adm: O) | ZEPOSIA CAPS 0.92MG/CAP BTx28 καψάκια σε Βlisters PVC/PCTFE/alu | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting;Colitis, Ulcerative | BRISTOL-MYERSSQUIBBPHARMAEEIG,IRELAND |
Greece | (L04AE03) siponimod | MAYZENT F.C.TAB 0.25MG/TAB Συσκευασία τιτλοποίησης: 12 δισκία σε Blisters PA/alu/PVC/Alu | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | NOVARTISEUROPHARMLIMITED,IRELAND |
Greece | (L04AE03) siponimod | MAYZENT F.C.TAB 1MG/TAB 28 δισκία σε Blisters PA/alu/PVC/Alu | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | NOVARTISEUROPHARMLIMITED,IRELAND |
Greece | (L04AE03) siponimod | MAYZENT F.C.TAB 2MG/TAB 28 δισκία σε Blisters PA/alu/PVC/Alu | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | NOVARTISEUROPHARMLIMITED,IRELAND |
Greece | (L04AE04) ponesimod (adm: O) | PONVORY F.C.TAB 10MG/TAB συσκευασία έναρξης ΣΥΣΚΕΥΑΣΙΑ ΕΝΑΡΞΗΣ ΘΕΡΑΠΕΙΑΣ: 14 ΔΙΣΚΙΑ ΤΩΝ (2X2MG+2X3MG+2X4MG+1X5MG+1X6MG+1X7MG+1X8MG+1X9MG+3X10MG) ΣΕ BLISTERS OPA/ALU/PE+DES/PET/ALU/PE | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | LABORATOIRESJUVISEPHARMACEUTICALS,FRANCE |
Greece | (L04AE04) ponesimod (adm: O) | PONVORY F.C.TAB 20MG/TAB συσκευασία συντήρησης 28 ΔΙΣΚΙΑ ΣΕ BLISTERS OPA/ALU/PE+DES/PET/ALU/PE | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | LABORATOIRESJUVISEPHARMACEUTICALS,FRANCE |
Greece | (L04AF01) tofacitinib (adm: O) | XELJANZ F.C.TAB 5MG/TAB BT x 56 δισκία σε κυψέλη (alu/PVC/alu) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | PFIZEREUROPEMAEEIG,BELGIUM |
Greece | (L04AF03) upadacitinib (adm: O) | RINVOQ PR.TAB 15MG/TAB BTx28 δισκία σε BLISTERS (PVC/PE/PCTFE/alu) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | ABBVIEDEUTSCHLANDGMBH&COKG,LUDWIGSHAFEN,GERMANY |
Greece | (L04AF03) upadacitinib (adm: O) | RINVOQ PR.TAB 30MG/TAB BT Χ 28 ΔΙΣΚΙΑ ΣΕ BLISTERS PVC/PE/PCTFE/ALU | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | ABBVIEDEUTSCHLANDGMBH&COKG,LUDWIGSHAFEN,GERMANY |
Greece | (L04AF03) upadacitinib (adm: O) | RINVOQ PR.TAB 45MG/TAB BT Χ 28 ΔΙΣΚΙΑ ΣΕ BLISTERS PVC/PE/PCTFE/ALU | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | ABBVIEDEUTSCHLANDGMBH&COKG,LUDWIGSHAFEN,GERMANY |
Greece | (L04AF04) filgotinib (adm: O) | JYSELECA® F.C.TAB 100MG/TAB ΦΙΑΛΗ (HDPE) x 30 δισκία | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | ALFASIGMAS.P.A.,ITALY |
Greece | (L04AF04) filgotinib (adm: O) | JYSELECA® F.C.TAB 200MG/TAB ΦΙΑΛΗ (HDPE) x 30 δισκία | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | ALFASIGMAS.P.A.,ITALY |
Greece | (L04AF07) deucravacitinib (adm: O) | SOTYKTU F.C.TAB 6MG/TAB BT X 28 (2 Χ 14) ΔΙΣΚΙΑ ΣΕ ΗΜΕΡΟΛΟΓΙΑΚΑ BLISTERS (PVC/PCTFE/ALU) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis | BRISTOL-MYERSSQUIBBPHARMAEEIG,IRELAND |
Greece | (L04AF08) ritlecitinib (adm: O) | LITFULO CAPS 50MG/CAP BT X 30 ΚΑΨΑΚΙΑ ΣΕ ΚΥΨΕΛΗ (OPA/ALU/PVC/ALU) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Alopecia Areata | PFIZEREUROPEMAEEIG,BELGIUM |
Greece | (L04AG03) natalizumab (adm: P) | TYSABRI C/S.SOL.IN 300MG/VIAL (20MG/ML) BT x 1 VIAL x 15 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Sclerosis | BIOGENNETHERLANDSB.V.,THENETHERLANDS |
Greece | (L04AG03) natalizumab (adm: P) | TYSABRI® INJ.SOL 150MG/ML BT X 2 PF.SYR | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Sclerosis | BIOGENNETHERLANDSB.V.,THENETHERLANDS |
Greece | (L04AG04) belimumab (adm: P) | BENLYSTA INJ.SOL 200MG/1ML BTx4 PF.PENS x1ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GLAXOSMITHKLINE(IRELAND)LIMITED,IRELAND |
Greece | (L04AG04) belimumab (adm: P) | BENLYSTA PD.C.SO.IN 120MG/VIAL BTx1VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GLAXOSMITHKLINE(IRELAND)LIMITED,IRELAND |